Study S000897

An Investigation of the Effect of High Dose s.c. Semaglutide on Gastric Emptying in Participants With Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07845578
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 60
Start: 2026-09-25
Primary completion: 2027-09-11
Lead sponsor: Novo Nordisk A/S
Conditions: Obesity; Overweight
Interventions: DRUG:Semaglutide; DRUG:Placebo semaglutide; DRUG:Paracetamol
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1335-9563; OTHER:2026-526083-20

Registered primary outcomes

AUC,para: The area under the paracetamol plasma concentration-time curve following a standardised meal [Day 177]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.